#tradingfloorai |
#ANIC |
#RevenueGrowth #SignificantRevenue | Tropic Biosciences, a portfolio company of Agronomics Limited, raised $105 million in a Series C financing round to scale the commercial rollout of gene-edited tropical crops, particularly bananas and rice. The funding will accelerate global production, strengthen supply chains, and advance climate-resilient crop pipelines. Tropic launched innovative banana varieties in 2025, including a non-browning banana and an extended shelf-life variety, reducing waste and increasing yields. The round was co-led by Forbion and Corteva, with participation from new and existing investors. Agronomics, a leading clean food investment firm, highlighted Tropics role in addressing global food challenges through gene-editing technology. Read More@:
rnsai.com/digest/master_…